Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Journal of Medical Economics|November 6, 2014
Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the USChristopher M Blanchette, Christopher Craver, Kathy W Belk, et al.Journal of the American Society of Nephrology : JASN|June 14, 2014
Predictors of autosomal dominant polycystic kidney disease progressionRobert W Schrier, Godela Brosnahan, Melissa A Cadnapaphornchai, et al.Journal of Nephrology|October 19, 2006
Autosomal dominant polycystic kidney disease coexisting with cystic fibrosisNancy Xu, James F Glockner, Sandro Rossetti, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 25, 2002
The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1Denise Walker, Mark Consugar, Jeff Slezak, et al.Journal of Health Economics and Outcomes Research|September 4, 2023
Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney DiseaseChristopher M Blanchette, Şerban R Iorga, Aylin Altan, et al.Human Molecular Genetics|March 7, 2003
PKHDL1, a homolog of the autosomal recessive polycystic kidney disease gene, encodes a receptor with inducible T lymphocyte expressionMarie C Hogan, Matthew D Griffin, Sandro Rossetti, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 25, 2011
Integrated strategies for allogeneic blood saving in major elective surgeryMaria Beatrice Rondinelli, Francesco Pallotta, Sandro Rossetti, et al.Kidney International|April 23, 2002
A complete mutation screen of the ADPKD genes by DHPLCSandro Rossetti, Dominique Chauveau, Denise Walker, et al.Molecular Genetics and Metabolism|September 16, 2011
A novel application of pattern recognition for accurate SNP and indel discovery from high-throughput data: targeted resequencing of the glucocorticoid receptor co-chaperone FKBP5 in a Caucasian populationLinda L Pelleymounter, Irene Moon, Julie A Johnson, et al.Drugs in Context|April 30, 2015
Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney diseaseChristopher M Blanchette, Caihua Liang, Deborah P Lubeck, et al.Pageof 6